Global /Canada /Healthcare /Drug Manufacturers - Specialty & Generic /AION

Aion Therapeutic Inc.

AION

• CSE: AION • Delayed

0.0050CAD 0%

0.0036 USD

As of 6 June 2026, Aion Therapeutic Inc. has a market cap of $1.78M USD, ranking #47432 globally and #2491 in Canada. It ranks #4212 in the Healthcare sector, and #327 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

47432

Country Rank

2491

Sector Rank

4212

Industry Rank

327

Key Stats

Market Cap

$1.78MUSD

2.49M CAD

Enterprise Value

$3.79MUSD

5.28M CAD

Revenue (TTM)

$1.06MUSD

1.47M CAD

EBITDA (TTM)

-$1.07MUSD

-1.49M CAD

Net Income (TTM)

-$4.76MUSD

-6.65M CAD

EBITDA Margin

-101%

PS Ratio

1.7

PB Ratio

-0.5

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

John Simmonds open_in_new

Employees

Founded

2011

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	-50%	-50%	-50%	-50%	-67%	-50%	-95%

Upcoming Earnings

Earnings Date

Fri, Jul 10

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	AION Aion Therapeutic Inc Ordinary Shares ISIN: CA00905T1021 Shares Out.: Shares Outstanding: 483.549M¹ Shares Float: 437.377M² TV: TradingView: CSE: AION SA: Stock Analysis: CSE: AION YF: Yahoo Finance: AION.CN GF: Google Finance: CNSX: AION BA: Barron's: AION MS: Morningstar: XCNQ: AION	0.0050 CAD	TV: TradingView: CSE: AION SA: Stock Analysis: CSE: AION YF: Yahoo Finance: AION.CN GF: Google Finance: CNSX: AION BA: Barron's: AION MS: Morningstar: XCNQ: AION
OTC Markets (OTCMKTS / OTC) MIC: OTCM	ANTCF Aion Therapeutic Inc Ordinary Shares ISIN: CA00905T1021 TV: TradingView: OTC: ANTCF SA: Stock Analysis: OTC: ANTCF YF: Yahoo Finance: ANTCF GF: Google Finance: OTCMKTS: ANTCF BA: Barron's: ANTCF MS: Morningstar: PINX: ANTCF	0.0017 USD	TV: TradingView: OTC: ANTCF SA: Stock Analysis: OTC: ANTCF YF: Yahoo Finance: ANTCF GF: Google Finance: OTCMKTS: ANTCF BA: Barron's: ANTCF MS: Morningstar: PINX: ANTCF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Aion Therapeutic Inc.

Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Canada)

Name	Market Cap (USD) diff.	PE	Country
Bausch Health Companies Inc. TSX: BHC	$2.08B 2.9B CAD 116K%	13.5	Canada
Jamieson Wellness Inc. TSX: JWEL	$999.68M 1.39B CAD 56K%	23.0	Canada
Cronos Group Inc. TSX: CRON	$983.67M 1.37B CAD 55K%	-	Canada
Cipher Pharmaceuticals Inc. TSX: CPH	$332.74M 464.15M CAD 19K%	12.7	Canada
Cannara Biotech Inc. TSXV: LOVE	$126.05M 175.83M CAD 7K%	14.9	Canada
Noveris Health Sciences Inc. CSE: NVRS	$83.94M 117.1M CAD 5K%	1.1	Canada

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 2M%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 2M%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 890K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 624K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 617K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 511K%	80.6	China

chevron_leftBack